Results 181 to 182 of about 6,146 (182)
Some of the next articles are maybe not open access.

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

Redox Biology, 2017
Sebastian Steven   +2 more
exaly  

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial

Lancet Diabetes and Endocrinology,the, 2014
exaly  
medicine
diabetes mellitus
endocrinology
type 2 diabetes
internal medicine
type 2 diabetes mellitus
heart failure
chemistry
pharmacology
previous   17  18  19  

Home - About - Disclaimer - Privacy